Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (Dry AMD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Advanced Cell Technology
Sponsor:
Information provided by (Responsible Party):
Advanced Cell Technology
ClinicalTrials.gov Identifier:
NCT01344993
First received: April 28, 2011
Last updated: November 3, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)
No publications provided by Advanced Cell Technology

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):